Literature DB >> 31563232

Inpatient Management of Migraine.

Michael J Marmura1, Angela Hou2.   

Abstract

Migraine is a frequently disabling neurologic condition which can be complicated by medication overuse headache and comorbid medical disorders, including obesity, anxiety and depression. Although most migraine management takes place in outpatient clinics, inpatient treatment is indicated for migraine refractory to multiple outpatient treatments, with intractable nausea or vomiting, need for detoxification from medication overuse (such as opioids and barbiturates), and significant medical and psychiatric disease. The goals of inpatient treatment include breaking the current cycle of headache pain, reducing the frequency and/or severity of future attacks, monitored detoxification of overused medications, and reducing disability and improving quality of life.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic migraine; Inpatient management; Medication overuse; Refractory headache

Mesh:

Year:  2019        PMID: 31563232     DOI: 10.1016/j.ncl.2019.07.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  2 in total

Review 1.  Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine.

Authors:  Jeffrey J Mojica; Eric S Schwenk; Clinton Lauritsen; Stephanie J Nahas
Journal:  Curr Pain Headache Rep       Date:  2021-12-11

2.  European headache federation consensus on the definition of resistant and refractory migraine : Developed with the endorsement of the European Migraine & Headache Alliance (EMHA).

Authors:  Simona Sacco; Mark Braschinsky; Anne Ducros; Christian Lampl; Patrick Little; Antoinette Maassen van den Brink; Patricia Pozo-Rosich; Uwe Reuter; Elena Ruiz de la Torre; Margarita Sanchez Del Rio; Alexandra J Sinclair; Zaza Katsarava; Paolo Martelletti
Journal:  J Headache Pain       Date:  2020-06-16       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.